Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Tryptophan no turkey in boosting immune system


Tryptophan is the source of Thanksgiving legend and grist for a "Seinfeld" episode, but it’s not the chemical that you’d expect to find in Lawrence Steinman’s lab.

A professor of neurology and neurological sciences and chair of the immunology program, Steinman, MD, and his lab generally focus on high-tech genetic therapies for diseases of the brain and nervous system. But his latest paper, to be published in the Nov. 4 issue of Science, breaks new ground on the effects of tryptophan - an amino acid found in turkey, among other foods, that is rumored to cause extreme post-Thanksgiving-feast sleepiness. It was featured in "Seinfeld" as a way for Jerry to knock out a woman by feeding her turkey so he could play with her classic toy collection.

The myth of tryptophan in turkey causing inordinate sleepiness has been debunked (tryptophan only works on the brain when ingested on an empty stomach). But the amino acid itself does play a vital role in sleep and in control of mood. And Steinman’s findings add to the growing body of evidence indicating that tryptophan plays a pivotal role in the immune system.

In an animal model, Steinman’s group has found that certain tryptophan metabolites - molecules formed as the body breaks down the amino acid - work as well as any other existing medicines to alleviate multiple sclerosis symptoms. In multiple sclerosis, the immune system launches an attack against the myelin sheath, the fatty cells that insulate neurons. The resulting variety of neurological disorders affects more than 2.5 million people worldwide.

Soothing the overactive immune system of autoimmune diseases such as multiple sclerosis requires something that can suppress the attack. In their studies, the team discovered that a drug chemically similar to metabolized tryptophan is suppressive to the immune system. This drug, marketed as tranilast, has been used abroad in clinical trials for other indications and appears safe.

"The bigger message here is that diet and immunity are inextricably linked," said Steinman. The intersection between diet and the immune system has not been well-studied, he said, "but now all of a sudden we have this really interesting science that ties tranilast up with tryptophan, underscoring the remarkable effect diet can have on immunity."

For all his current enthusiasm, Steinman was a reluctant entrant into the world of tryptophan research. When one of the lead authors, German postdoctoral researcher Michael Platten, MD, PhD, approached Steinman in 2002 with his idea to try tranilast in Steinman’s models of multiple sclerosis, Steinman thought it was one of the worst project proposals he had ever heard. The drug wasn’t invented at Stanford and was already being used for a range of maladies. Steinman prefers to create his own therapies.

But Platten had his own funding through the privately held Australian company Angiogen Pharmaceuticals, so Steinman was game to see where the idea could go. None of the Stanford researchers have any financial ties to the company. Michael Selley, MD, Angiogen Pharmaceuticals’ CEO and founder, is listed as one of the paper’s 13 co-authors.

Platten and Peggy Ho, PhD, a postdoctoral researcher in Steinman’s lab, performed a rigorous series of experiments using mouse cells and a mouse model of multiple sclerosis called experimental autoimmune encephalomyelitis, or EAE. The team detailed the effect of four tryptophan metabolites as well as tranilast, a synthetic derivative of tryptophan.

The researchers found that all of the chemicals alleviated symptoms of mice with EAE. They also found that if they injected EAE mice with immune cells from other mice that had been protected with treatment, they could transfer the protective effect of the tryptophan metabolites. "That was a very powerful result," said Ho. "I had been skeptical of this project, but I was amazed when I saw that."

Transference of protection indicates that the treatment might trigger regulatory T cells, cells that suppress immune response rather than activate it. Steinman admitted that the only explanations of this phenomenon currently amount to "hand waving."

"One of the questions that is bound to come up with all this is, ’So, doctor, if I eat a lot of this or that, can I cure my autoimmune disease?’" said Steinman. "Even though many of the things we study in the lab, like tryptophan, modulate the immune system, are there practical things you can do in your diet to make a difference? My answer to that is ’I don’t know.’"

Steinman speculated that given the proven safety record of tranilast, as well as its apparent ability to suppress autoimmune diseases, it might be a practical way to achieve the benefits of tryptophan breakdown products without the complications of manipulating tryptophan consumption.

Mitzi Baker | EurekAlert!
Further information:

More articles from Studies and Analyses:

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

TRAPPIST-1 planets provide clues to the nature of habitable worlds

21.03.2018 | Physics and Astronomy

The search for dark matter widens

21.03.2018 | Materials Sciences

Natural enemies reduce pesticide use

21.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>